• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常铁状态与腹膜透析相关性腹膜炎的发生和预后的关系:一项基于纵向数据的 10 年回顾性研究。

Association of Abnormal Iron Status with the Occurrence and Prognosis of Peritoneal Dialysis-Related Peritonitis: A Longitudinal Data-Based 10-Year Retrospective Study.

机构信息

Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou 510080, China.

Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China.

出版信息

Nutrients. 2022 Apr 13;14(8):1613. doi: 10.3390/nu14081613.

DOI:10.3390/nu14081613
PMID:35458175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027868/
Abstract

This retrospective study investigated the effect of iron status on peritonitis by analyzing longitudinal iron parameters in peritoneal dialysis (PD) patients. Patients who received PD at our center from 1 January 2006 to 31 December 2015 were included and followed up until 31 December 2017. According to the joint quartiles of baseline transferrin saturation and ferritin, iron status was categorized as reference iron status (RIS), absolute iron deficiency (AID), functional iron deficiency (FID), and high iron status (HIS). Generalized estimating equations and Cox regression models with time-dependent covariates were used. A total of 1258 PD patients were included; 752 (59.8%) were male, with a mean (±standard deviation) age of 47.4 (±14.9) years. During a median follow-up period of 35.5 (interquartile range, 18.4-60.0) months, 450 (34.3%) patients had 650 episodes of peritonitis. By analyzing longitudinal data, patients with AID were independently positively associated with the occurrence (adjusted odds ratio (AOR) = 1.45) and treatment failure of peritonitis (adjusted hazard ratio (AHR) = 1.85). Patients with HIS were positively associated with the treatment failure of peritonitis (AHR = 2.70). Longitudinal AID and HIS were associated with the episodes and poor prognosis of peritonitis. Active clinical monitoring and correction of iron imbalance in patients with PD are needed.

摘要

这项回顾性研究通过分析腹膜透析(PD)患者的纵向铁参数,探讨了铁状态对腹膜炎的影响。纳入 2006 年 1 月 1 日至 2015 年 12 月 31 日期间在我院接受 PD 治疗并随访至 2017 年 12 月 31 日的患者。根据基线转铁蛋白饱和度和铁蛋白的联合四分位值,将铁状态分为参考铁状态(RIS)、绝对铁缺乏(AID)、功能性铁缺乏(FID)和高铁状态(HIS)。使用广义估计方程和 Cox 回归模型进行时间依赖性协变量分析。共纳入 1258 例 PD 患者,其中 752 例(59.8%)为男性,平均年龄(±标准差)为 47.4(±14.9)岁。中位随访时间为 35.5(四分位距,18.4-60.0)个月,共有 450 例(34.3%)患者发生 650 次腹膜炎。通过分析纵向数据,AID 患者发生腹膜炎的几率(校正比值比(AOR)=1.45)和治疗失败(校正风险比(AHR)=1.85)独立呈正相关。HIS 患者与腹膜炎治疗失败呈正相关(AHR=2.70)。纵向 AID 和 HIS 与腹膜炎发作和不良预后有关。需要对 PD 患者进行积极的临床监测和纠正铁失衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/b29cccd5ccdb/nutrients-14-01613-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/75446fcdfa1c/nutrients-14-01613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/258fd967c4d1/nutrients-14-01613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/b29cccd5ccdb/nutrients-14-01613-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/75446fcdfa1c/nutrients-14-01613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/258fd967c4d1/nutrients-14-01613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec0/9027868/b29cccd5ccdb/nutrients-14-01613-g003.jpg

相似文献

1
Association of Abnormal Iron Status with the Occurrence and Prognosis of Peritoneal Dialysis-Related Peritonitis: A Longitudinal Data-Based 10-Year Retrospective Study.异常铁状态与腹膜透析相关性腹膜炎的发生和预后的关系:一项基于纵向数据的 10 年回顾性研究。
Nutrients. 2022 Apr 13;14(8):1613. doi: 10.3390/nu14081613.
2
Abnormal iron status is associated with an increased risk of mortality in patients on peritoneal dialysis.异常的铁状态与腹膜透析患者的死亡率增加有关。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1148-1155. doi: 10.1016/j.numecd.2020.12.018. Epub 2021 Feb 19.
3
Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.中心效应与腹膜透析相关性腹膜炎结局:全国登记数据分析。
Am J Kidney Dis. 2018 Jun;71(6):814-821. doi: 10.1053/j.ajkd.2017.10.017. Epub 2017 Dec 28.
4
Lower education level is a major risk factor for peritonitis incidence in chronic peritoneal dialysis patients: a retrospective cohort study with 12-year follow-up.文化程度低是慢性腹膜透析患者腹膜炎发病的主要危险因素:一项 12 年随访的回顾性队列研究。
Perit Dial Int. 2013 Sep-Oct;33(5):552-8. doi: 10.3747/pdi.2012.00065. Epub 2013 Apr 1.
5
The Iron Biology Status of Peritoneal Dialysis Patients May Be a Risk Factor for Development of Infectious Peritonitis.腹膜透析患者的铁生物学状态可能是发生感染性腹膜炎的一个危险因素。
Perit Dial Int. 2019 Jul-Aug;39(4):362-374. doi: 10.3747/pdi.2018.00052. Epub 2019 May 23.
6
Impact of peritoneal dialysis-related peritonitis on PD discontinuation and mortality: A population-based national cohort study.腹膜透析相关腹膜炎对腹膜透析终止及死亡率的影响:一项基于全国人群的队列研究。
Perit Dial Int. 2022 Mar;42(2):194-203. doi: 10.1177/08968608211018949. Epub 2021 Jun 8.
7
Effect of different dialysis duration on the prognosis of peritoneal dialysis-associated peritonitis: a single-center, retrospective study.不同透析时间对腹膜透析相关性腹膜炎预后的影响:一项单中心、回顾性研究。
Ren Fail. 2023 Dec;45(1):2177496. doi: 10.1080/0886022X.2023.2177496.
8
Outcome and complications in peritoneal dialysis patients: a five-year single center experience.腹膜透析患者的结局与并发症:一项为期五年的单中心经验
Saudi J Kidney Dis Transpl. 2011 Mar;22(2):245-51.
9
Peritonitis: Episode Sequence, Microbiological Variation, Risk Factors and Clinical Outcomes in a North China Peritoneal Dialysis Center.腹膜炎:中国北方腹膜透析中心的发病过程、微生物学变化、危险因素及临床结局
Kidney Blood Press Res. 2018;43(5):1573-1584. doi: 10.1159/000494443. Epub 2018 Oct 22.
10
Incidence of peritonitis in chronic peritoneal dialysis patients infused with intravenous iron dextran.接受静脉注射右旋糖酐铁的慢性腹膜透析患者腹膜炎的发生率。
Perit Dial Int. 2000 Nov-Dec;20(6):674-8.

引用本文的文献

1
Assessment of iron metabolism and iron deficiency in incident patients on incident continuous ambulatory peritoneal dialysis.新接受持续性非卧床腹膜透析患者铁代谢及缺铁情况的评估
Open Med (Wars). 2024 Sep 17;19(1):20241035. doi: 10.1515/med-2024-1035. eCollection 2024.
2
Glycosylation and Characterization of Human Transferrin in an End-Stage Kidney Disease.人转铁蛋白在终末期肾病中的糖基化及特性分析。
Int J Mol Sci. 2024 Apr 24;25(9):4625. doi: 10.3390/ijms25094625.
3
Iron status and anemia control are related to peritoneal membrane properties in peritoneally dialyzed patients.

本文引用的文献

1
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.慢性肾脏病患者的铁状态、成纤维细胞生长因子 23 与心血管及肾脏结局。
Kidney Int. 2021 Dec;100(6):1292-1302. doi: 10.1016/j.kint.2021.07.013. Epub 2021 Jul 30.
2
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.血清铁储存生物标志物与非透析 CKD 患者(无论是否贫血)全因死亡率和心血管事件风险增加相关。
J Am Soc Nephrol. 2021 Aug;32(8):2020-2030. doi: 10.1681/ASN.2020101531. Epub 2021 Jul 8.
3
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
铁状态和贫血控制与腹膜透析患者的腹膜特性相关。
Front Med (Lausanne). 2023 Jul 6;10:1148094. doi: 10.3389/fmed.2023.1148094. eCollection 2023.
4
Benefits and risks of essential trace elements in chronic kidney disease: a narrative review.慢性肾脏病中必需微量元素的益处与风险:一项叙述性综述
Ann Transl Med. 2022 Dec;10(24):1400. doi: 10.21037/atm-22-5969.
最佳贫血管理中的争议:来自改善全球肾脏病预后组织(KDIGO)会议的结论
Kidney Int. 2021 Jun;99(6):1280-1295. doi: 10.1016/j.kint.2021.03.020. Epub 2021 Apr 8.
4
Abnormal iron status is associated with an increased risk of mortality in patients on peritoneal dialysis.异常的铁状态与腹膜透析患者的死亡率增加有关。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1148-1155. doi: 10.1016/j.numecd.2020.12.018. Epub 2021 Feb 19.
5
Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk.慢性肾脏病中的铁剂管理、感染与贫血管理:解析静脉铁剂治疗对免疫及感染风险的影响
Kidney Med. 2020 Mar 27;2(3):341-353. doi: 10.1016/j.xkme.2020.01.006. eCollection 2020 May-Jun.
6
Adaptation to iron deficiency in human pathogenic fungi.人体病原真菌对缺铁环境的适应。
Biochim Biophys Acta Mol Cell Res. 2020 Oct;1867(10):118797. doi: 10.1016/j.bbamcr.2020.118797. Epub 2020 Jul 11.
7
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial.静脉铁剂给药与血液透析患者感染风险:PIVOTAL 试验的预先设定二次分析。
J Am Soc Nephrol. 2020 May;31(5):1118-1127. doi: 10.1681/ASN.2019090972. Epub 2020 Apr 6.
8
Incidence and risk factors of peritoneal dialysis-related peritonitis in elderly patients: A retrospective clinical study.老年患者腹膜透析相关性腹膜炎的发生率及危险因素:一项回顾性临床研究。
Perit Dial Int. 2020 Jan;40(1):26-33. doi: 10.1177/0896860819879868.
9
International Anemia Prevalence and Management in Peritoneal Dialysis Patients.国际腹膜透析患者贫血的患病率及管理。
Perit Dial Int. 2019 Nov-Dec;39(6):539-546. doi: 10.3747/pdi.2018.00249. Epub 2019 Oct 3.
10
An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.患有透析前慢性肾脏病的糖尿病和非糖尿病退伍军人中,异常铁状态与死亡率升高相关。
Kidney Int. 2019 Sep;96(3):750-760. doi: 10.1016/j.kint.2019.04.029. Epub 2019 May 15.